Effect of Extra-Virgin Olive Oil on Hand Foot Syndrome and hs-CRP in Patients Receiving Capecitabine: A Randomized Trial

Effect of Extra-Virgin Olive Oil on Hand Foot Syndrome and hs-CRP in Patients Receiving Capecitabine: A Randomized Trial

Background: Hand Foot Syndrome (HFS) is a frequent adverse effect observed in patients undergoing capecitabine chemotherapy, often leading to treatment disruptions and dose adjustments. Elevated C-Reactive Protein (hs-CRP) levels have been associated with the development of HFS. This study aimed to...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yenny Dian Andayani, Mgs. Irsan Saleh, Aru Wisaksono Sudoyo, Zulkhair Ali, Legiran Legiran, Radiyati Umi Partan, Eddy Yuristo, Fadhyl Zuhry Lubis
Format:	Article
Language:	English
Published:	Interna Publishing 2024-01-01
Series:	Acta Medica Indonesiana
Subjects:	Hand Foot Syndrome C-Reactive Protein Extra Virgin Olive Oil Capecitabine
Online Access:	http://www.actamedindones.org/index.php/ijim/article/view/2534
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of Virgin Coconut Oil and Virgin Olive Oil on Perineal Laceration
by: Nor Asiyah, et al.
Published: (2018-03-01)

Clinical pharmacokinetics of capecitabine and its metabolites in colorectal cancer patients
by: Saeed Alqahtani, et al.
Published: (2022-05-01)

CAPECITABINE IN THE TREATMENT OF BRAIN METASTATIC LESION IN PATIENTS WITH BREAST CANCER
by: E. A. Moskvina, et al.
Published: (2015-04-01)

Adherence and safety study in patients on treatment with capecitabine
by: Francisca Fernández-Ribeiro, et al.
Published: (2017-03-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

Oxaliplatin combined with capecitabine therapy and comprehensive nursing in advanced colorectal cancer patients
by: Dan Kuang, et al.
Published: (2025-07-01)

Dupilumab for management of capecitabine-induced hand-foot syndrome
by: Ian Nykaza, BS, et al.
Published: (2025-09-01)

Development of an Early-Warning Model for Predicting the Capecitabine-Induced Diarrhea
by: Liu Z, et al.
Published: (2025-06-01)

ACUTE MYOCARDIAL INFARCTION IN THE ABSENCE OF CORONARY ARTERY OBSTRUCTION – A COMPLICATION OF ANTICANCER THERAPY WITH CAPECITABINE
by: E. A. Kolomiets, et al.
Published: (2017-12-01)

Virginity as a sign of Masculinity: The case of the Borana Oromo, Ethiopia
by: Dejene Gemechu Chala, et al.
Published: (2023-12-01)

Incidence of myocardial ischemia during treatment with capecitabine: a cohort study with Holter recording and cardiac biomarkers
by: Anne Dyhl-Polk, et al.
Published: (2025-07-01)

Midwives\' Views on Virginity Testing: A Cross-sectional Study
by: Somayyeh Naghizadeh, et al.
Published: (2023-06-01)

Immediate and long-term results of radiation therapy in combination with capecitabine and oxaliplatin in the treatment of patients with asquamous cell carcinoma of the anus
by: A. A. Nevolskikh, et al.
Published: (2023-09-01)

Disturbance of bile acids profile aggravates the diarrhea induced by capecitabine through inhibiting the Wnt/β-catenin pathway
by: Zhipeng Wang, et al.
Published: (2025-06-01)

Cost-effectiveness analysis of capecitabine versus active monitoring in stable or responding metastatic colorectal cancer after 16 weeks of first-line therapy
by: Tong Liu, et al.
Published: (2025-12-01)

Comparative study of low dose of capecitabine versus standard dose in metastatic breast cancer: Efficacy and safety
by: Aboelnaga Engy M, et al.
Published: (2021-08-01)

The Effect of Topical Heparin Gel on Reducing Hand–Foot Syndrome Symptoms in Cancer Patients Treated with Capecitabine
by: Maede Mirjalili, et al.

Implications for the future and recommendations for modifications to current regulations concerning virgin olive oil
by: Claudio Peri, et al.
Published: (1994-04-01)

Randomized, phase II trial to evaluate the efficacy and safety of atezolizumab plus capecitabine adjuvant therapy compared to capecitabine monotherapy for triple receptor-negative breast cancer with residual invasive cancer after neoadjuvant chemotherapy (MIRINAE trial, KCSG-BR18-21)
by: Jieun Lee, et al.
Published: (2025-08-01)

Differential expression of capecitabine-related metabolic enzymes in hepatocellular carcinoma and its clinical value: a retrospective cohort study
by: Jianing Lu, et al.
Published: (2025-06-01)

Cetuximab-Taxanes-Platinum-Fluorouracil/Capecitabine (C-TPF/C-TPX) – a Feasible Option for Recurrent HNSCC with Negative Prognostic Factors. Literature Review with a Case Presentation
by: Camil Ciprian MIRESTEAN, et al.
Published: (2023-03-01)

IMMEDIATE RESPONSE TO NEOADJUVANT CHEMOTHERAPY INCLUDING CAPECITABINE AND LONG-TERM TREATMENT OUTCOMES OF OPERABLE BREAST CANCER
by: E. M. Slonimskaya, et al.
Published: (2016-07-01)

Five‐year results of a phase II trial of preoperative 5‐fluorouracil, epirubicin, cyclophosphamide followed by docetaxel with capecitabine (wTX) (with trastuzumab in HER2‐positive patients) for patients with stage II or III breast cancer
by: Frankie Ann Holmes, et al.
Published: (2018-06-01)

A Case Report Capecitabine-Induce Grade II Hand and Foot Syndrome
by: Nurul Damayanti, et al.
Published: (2025-07-01)

Sensory profiling: a method for describing the sensory characteristics of virgin olive oil
by: David H. Lyon, et al.
Published: (1994-04-01)

Case report: A case of severe capecitabine toxicity due to confirmed in trans compound heterozygosity of a common and rare DPYD variant
by: Amy de Haar-Holleman, et al.
Published: (2024-09-01)

Lanolin-based dexpanthenol cream, topical hydrocortisone or observation in the prevention of capecitabine-induced hand-foot syndrome: a phase III trial
by: Cintia Sayuri Kurokawa La-Scala, et al.
Published: (2022-12-01)

Uterine procidentia in a virgin woman: A rare case
by: Nastaran Mahmoudnejad, et al.
Published: (2024-11-01)

EVERYDAY LIFE AND DEMOGRAPHIC PROCESSES IN VIRGIN LANDS OF ORENBURG REGION
by: O. Kuznetsova
Published: (2021-09-01)

Comparative Analysis of Clinical Efficacy and Safety of Pyrotinib Plus Capecitabine versus Trastuzumab Emtansine (T-DM1) as Second-Line Treatment for HER2-Positive Advanced Breast Cancer: A Retrospective Study
by: Han H, et al.
Published: (2025-04-01)

Case Report: Cardiotoxicity of capecitabine may manifest as STEMI with significant left ventricular cardiac dysfunction and recurrent supraventricular and ventricular arrhythmias: a proposal for optimal diagnosis and treatment
by: Sebastian Szmit, et al.
Published: (2025-06-01)

Docetaxel, Oxaliplatin with Capecitabine (TEX Regimen) in Metastatic Gastric and Gastroesophageal Adenocarcinoma: A Prospective Single-Arm Observational Study from a Tertiary Cancer Center in Kashmir
by: Sanudev Sadanandan Vadakke Puthiyottil, et al.
Published: (2025-04-01)

Drug Delivery by Carbon Nano Carrier for Use as Capecitabine Drug Carrier: A QM/MM study
by: Fahimeh Najafi
Published: (2025-01-01)

Efficacy of adjuvant capecitabine in triple-negative breast cancer with residual disease after neoadjuvant therapy: a real-world study
by: Youzhao Ma, et al.
Published: (2025-06-01)

Squamous Cell Cancer of the Skin in a Patient on Maintenance Capecitabine for Metastatic Breast Cancer: A Case Report
by: Sidharth Mahajan, et al.
Published: (2024-09-01)

Some nutritional benefits of extra virgin olive oil
by: S. Ciappellano, et al.
Published: (1994-04-01)

IMPROVING THE TECHNOLOGY OF EXTRA VIRGIN PEACH KERNEL OILS
by: Ye. Kotliar, et al.
Published: (2024-05-01)

Good Manufacturing Practice (GMP) guidelines for virgin olive oil production
by: Christos Petrakis
Published: (1994-04-01)

Characterization of a bio-based concrete using virgin cork aggregate
by: Samah Hariz, et al.
Published: (2022-12-01)

The sensory wheel of virgin olive oil
by: Jos Mojet, et al.
Published: (1994-04-01)